Mars launches world’s first pet biobank to drive breakthroughs in disease diagnosis & prevention

Mars Petcare announced an unprecedented scientific initiative designed to improve understanding of pet health and disease, and help scientists and veterinarians innovate individualised healthcare for pets. The MARS Petcare Biobank aims to be the largest, most comprehensive real-world study of its kind, recruiting 20,000 pets (10,000 dogs and 10,000 cats) across the US over 10 years. The biobank study will generate longitudinal physiological data from the samples collected and connected to other metadata to gain insights about changes in health status and understand the differences between pets that are healthy as they age and pets that develop diseases. By enrolling their pets in the study, pet owners will help enable new scientific discoveries to improve pet health for generations to come.

“We aim for this biobank to drive breakthroughs in scientific knowledge for the future of pet health,” said Poul Weihrauch, president, Mars Petcare. “Pets make our world better, so it makes sense that we are investing in state-of-the-art research in service of our purpose to make A BETTER WORLD FOR PETS.” The biobank is part of a long-standing commitment to investing in innovation, science, and technology. The company has a well-established history in driving transformative pet health innovation through the Waltham Petcare Science Institute.